Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Imidazole; 14-α demethylase, H+/K+ ATPase, Na+...
Synthetic peptide, retroviral envelope protein ...
Trichothecene mycotoxin produced by Fusarium.
Vinca alkaloid found in Catharanthus; microtubu...
Macrolide; peptidyl transferase inhibitor, prot...
Retinol (vitamin A) analog, binds RBP4; Des1 in...
Sulfonamide; folic acid synthesis inhibitor.
Neuropeptide found in Locusta migratoria.
p110γ PI3K inhibitor, potential TRPC1/5/6 nega...
PLK4 inhibitor.
Expectorant.
Peptide fragment
Apoptosis inducing agent.
Tyrphostin; VEGFR inhibitor.
Active compound found in turmeric; MST1 activat...
p110γ PI3K inhibitor.
COMT inhibitor.
Organoselenium compound found in selenium-enric...
Endogenous tachykinin peptide, involved in infl...
AT1 inhibitor.